NCT06373497View on ClinicalTrials.gov

Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Oligometastatic Disease
Interventions
DIAGNOSTIC_TEST

18-F-NaF Cardiac PET/MRI and

All eligible subjects will receive 18-F-NaF Cardiac PET/MRI at baseline and 6 months after the completion of radiotherapy where the heart is in the treatment field

DIAGNOSTIC_TEST

CT Angiogram

All eligible subjects will receive CT Angiogram at baselin

Trial Locations (1)

90048

RECRUITING

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Katelyn Atkins

OTHER

NCT06373497 - Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography | Biotech Hunter | Biotech Hunter